Relation between plasma and saliva concentrations of enoxacin, ciprofloxacin, and theophylline

被引:11
作者
Zhai, SP
Wei, XX
Parker, BM
Kunze, KL
Vestal, RE
机构
[1] DEPT VET AFFAIRS MED CTR,CLIN PHARMACOL & GERONTOL RES UNIT,BOISE,ID
[2] IDAHO STATE UNIV,COLL PHARM,DEPT PHARMACEUT SCI,POCATELLO,ID 83209
[3] UNIV WASHINGTON,SCH PHARM,DEPT MED CHEM,SEATTLE,WA 98195
[4] UNIV WASHINGTON,SCH PHARM,DEPT PHARMACEUT,SEATTLE,WA 98195
[5] UNIV WASHINGTON,SCH MED,DEPT MED,SEATTLE,WA 98195
[6] UNIV WASHINGTON,SCH MED,DEPT PHARMACOL,SEATTLE,WA 98195
关键词
ciprofloxacin; enoxacin; theophylline; plasma; saliva;
D O I
10.1097/00007691-199612000-00007
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
To assess the reliability of predicting plasma concentrations of enoxacin, ciprofloxacin, and theophylline from drug concentrations in saliva, six healthy volunteers received single oral doses of enoxacin, ciprofloxacin, and theophylline administered in combination on each of four separate study days, with different doses separated by at least 5 days. Drug concentrations were determined by a newly developed high-performance liquid chromatography (HPLC) assay, which could measure simultaneously all three drugs in plasma or saliva. Saliva data from the postabsorptive phase after drug administration were used to minimize the effects of variation in absorption. There were good correlations between saliva and plasma concentrations of enoxacin, ciprofloxacin, and theophylline (r = 0.91, 0.88, and 0.98, respectively). The mean (+/-SD) saliva-to-plasma (S/P) ratio for theophylline was 0.63 +/- 0.06 with a coefficient of variation (CV) of 7.9 +/- 2.7%. In contrast, the S/P ratios and CV values for enoxacin and ciprofloxacin were 0.72 +/- 0.21 and 28.9 +/- 11.1%, and 0.58 +/- 0.15 and 25.3 +/- 6.7%, respectively. Because of the large inter- and intraindividual variability, saliva concentrations of enoxacin and ciprofloxacin are not reliable for predicting plasma concentrations. However, saliva may be used reliably for predicting plasma concentrations of theophylline.
引用
收藏
页码:666 / 671
页数:6
相关论文
共 19 条
[1]   MULTIPLE-DOSE CIPROFLOXACIN KINETICS IN NORMAL SUBJECTS [J].
ARONOFF, GE ;
KENNER, CH ;
SLOAN, RS ;
POTTRATZ, ST .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (03) :384-388
[2]  
Barza M, 1988, Rev Infect Dis, V10 Suppl 1, pS241
[3]   SERUM SALIVA CORRELATIONS FOR THEOPHYLLINE IN ASTHMATICS [J].
BLANCHARD, J ;
HARVEY, S ;
MORGAN, WJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (06) :565-570
[4]   RELATIONSHIP BETWEEN SERUM AND SALIVA THEOPHYLLINE LEVELS IN PATIENTS WITH CYSTIC-FIBROSIS [J].
BLANCHARD, J ;
HARVEY, S ;
MORGAN, WJ .
THERAPEUTIC DRUG MONITORING, 1992, 14 (01) :48-54
[5]   LEVELS OF RIFAMPIN AND CIPROFLOXACIN IN NASAL SECRETIONS - CORRELATION WITH MIC90 AND ERADICATION OF NASOPHARYNGEAL CARRIAGE OF BACTERIA [J].
DAROUICHE, R ;
PERKINS, B ;
MUSHER, D ;
HAMILL, R ;
TSAI, S .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (05) :1124-1127
[6]   COULD SALIVA STAND FOR PLASMA IN THEOPHYLLINE MONITORING IN ASTHMATIC-CHILDREN - STILL A CONTROVERSIAL PROBLEM [J].
GAO, Y ;
PONS, G ;
REY, E ;
RICHARD, MO ;
DATHIS, P ;
BERTIN, L ;
THIROUX, G ;
DEBLIC, J ;
SCHEINMANN, P ;
OLIVE, G .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1992, 6 (4-5) :191-196
[7]   MULTIPLE-DOSE PHARMACOKINETICS AND SAFETY OF CIPROFLOXACIN IN NORMAL VOLUNTEERS [J].
GONZALEZ, MA ;
URIBE, F ;
MOISEN, SD ;
FUSTER, AP ;
SELEN, A ;
WELLING, PG ;
PAINTER, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (05) :741-744
[8]  
JABER M, 1987, ANN ALLERGY, V58, P105
[9]  
JONKMAN JHG, 1981, EUR J CLIN PHARMACOL, V20, P73, DOI 10.1007/BF00554670
[10]   MONITORING CHILDREN ON SUSTAINED-RELEASE THERAPY BY SALIVARY THEOPHYLLINE LEVELS [J].
KELLY, HW ;
HADLEY, WM ;
MURPHY, SA ;
SKIPPER, BG .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1981, 135 (02) :137-139